UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 30.

Bogowicz, M; Riesterer, O; Bundschuh, R A; Veit-Haibach, P; Hüllner, M; Studer, G; Stieb, S; Glatz, S; Pruschy, M; Guckenberger, M; Tanadini-Lang, S (2016). Stability of radiomic features in CT perfusion maps. Physics in Medicine and Biology, 61(24):8736-8749.

Guckenberger, M; Riesterer, O; Theile, G; Andratschke, N (2015). Herausforderungen und Chancen in der radioonkologischen Behandlung von Patienten im Alter. Schweizer Krebs-Bulletin, 35(3):257-260.

Guckenberger, M; Riesterer, O; Andratschke, N (2015). Extrakranielle Stereotaxie von Leber- und Pankreas Tumoren. info@onkologie, 1(2015):24-30.

Roesch, J; Guckenberger, M; Riesterer, O (2015). Individualisierte Radiotherapie des Pleuramesothelioms. Schweizer Zeitschrift für Onkologie, (4):24-30.

Krayenbuehl, J; Dimmerling, P; Ciernik, I F; Riesterer, O (2014). Clinical outcome of postoperative highly conformal versus 3D conformal radiotherapy in patients with malignant pleural mesothelioma. Radiation Oncology, 9:32.

Janssen, S; Glanzmann, C; Bauernfeind, P; Stieb, S; Studer, G; Brown, M; Riesterer, O (2014). Clinical experience of SIB-IMRT in anal cancer and selective literature review. Radiation Oncology, 9:199.

Lang, S; Zeitmetz, J; Ochsner, G; Schmid Daners, M; Riesterer, O; Klöck, S (2014). Development and evaluation of a prototype tracking system using the treatment couch. Medical Physics, 41(2):021720.

Hrbacek, J; Lang, S; Graydon, S N; Klöck, S; Riesterer, O (2014). Dosimetric comparison of flattened and unflattened beams for stereotactic ablative radiotherapy of stage I non-small cell lung cancer. Medical Physics, 41(3):031709.

Riesterer, O; Guckenberger, M (2014). Stereotaktische Strahlentherapie von Metastasen : Palliativer Effekt und Tumorkontrolle. Onkologe, 20(8):757-765.

Riesterer, O (2013). Extrakranielle stereotaktische Radiotherapie bei frühen nicht-kleinzelligen Bronchialkarzinomen und Oligometastasen. Praxis, 102(21):1309-1316.

Riesterer, O (2013). Individualisierte multimodale Therapie bei Patienten mit NSCLC im Stadium IIIA-N2. info@onkologie, (3):9-12.

Krayenbuehl, J; Riesterer, O; Graydon, S; Dimmerling, P; Kloeck, S; Ciernik, I F (2013). Intensity-modulated radiotherapy and volumetric-modulated arc therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy. Journal of Applied Clinical Medical Physics, 14(4):4130.

Studer, G; Linsenmeier, C; Riesterer, O; Najafi, Y; Brown, M; Yousefi, B; Bredell, M; Huber, G; Schmid, S; Studer, S; Zwahlen, R; Rordorf, T; Glanzmann, C (2013). Late term tolerance in head neck cancer patients irradiated in the IMRT era. Radiation Oncology, 8:259.

Lang, S; Riesterer, O (2013). Progress in Physics - Modern techniques in radiation oncology (invited article). Progress in Physics:online.

Kati, E; Riesterer, O (2012). Hepatobiliäre Karzinome. Neue Möglichkeiten der Radiotherapie. info@onkologie, 2(4):18-22.

Studer, G; Brown, M; Bredell, M; Graetz, K W; Huber, G; Linsenmeier, C; Najafi, Y; Riesterer, O; Rordorf, T; Schmid, S; Glanzmann, C (2012). Follow up after IMRT in oral cavity cancer: update. Radiation Oncology, 7:84.

Riesterer, O (2012). Angiogenese-Inhibitoren und Radiotherapie. Praxis, 101(16):1031-1037.

Riesterer, O; Matsumoto, F; Wang, L; Pickett, J; Molkentine, D; Giri, U; Milas, L; Raju, U (2011). A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastrophe. Investigational New Drugs, 29(3):514-522.

Torres, M A; Raju, U; Molkentine, D; Riesterer, O; Milas, L; Ang, K K (2011). AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo. Investigational New Drugs, 29(4):554-561.

Riesterer, O; Yang, Q; Raju, U; Torres, M; Molkentine, D; Patel, N; Valdecanas, D; Milas, L; Ang, K K (2011). Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers. International Journal of Radiation Oncology, Biology and Physics, 79(4):1179-1187.

Koto, M; Choi, H; Riesterer, O; Giri, U; Story, M D; Ha, C S; Raju, U (2011). Human lymphoma cells develop resistance to radiation in the presence of astrocytes in vitro. Anticancer Research, 31(1):33-38.

Riesterer, O; Oehler-Jänne, C; Jochum, W; Broggini-Tenzer, A; Vuong, V; Pruschy, M (2011). Ionizing radiation and inhibition of angiogenesis in a spontaneous mammary carcinoma and in a syngenic heterotopic allograft tumor model: a comparative study. Radiation Oncology, 6:66.

Riesterer, O (2011). Kombinierte Angiogenese-/Vaskulogenese-Inhibition und Radiotherapie. Leading Opinions. Hämatologie & Onkologie, (3):46-49.

Samaras, P; Geier, A; Riesterer, O; Dutkowski, P (2011). Tumore des biliären Trakts: Häufigkeit, Diagnostik und Therapie. Schweizer Zeitschrift für Onkologie, (2):26-31.

Skvortsova, I; Skvortsov, S; Raju, U; Stasyk, T; Riesterer, O; Schottdorf, E-M; Popper, B-A; Schiestl, B; Eichberger, P; Debbage, P; Neher, A; Bonn, G K; Huber, L A; Milas, L; Lukas, P (2010). Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse. Radiotherapy and Oncology, 96(1):108-115.

Dindo, D; Riesterer, O; Weber, A; Hahnloser, D (2010). Humanes Papillomavirus und Analkarzinom. Diagnose, Screening und Therapie. Der Gastroenterologe, 5(4):318-325.

Riesterer, O; Mason, K A; Raju, U; Yang, Q; Wang, L; Hittelman, W N; Ang, K K; Milas, L (2009). Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed. Radiotherapy and Oncology, 92(3):383-387.

Cho, H; Koto, M; Riesterer, O; Molkentine, D P; Giri, U; Milas, L; Story, M D; Ha, C S; Raju, U (2009). Imexon augments sensitivity of human lymphoma cells to ionizing radiation: in vitro experimental study. Anticancer Research, 29(11):4409-4415.

Riesterer, O; Gmür, J; Lütolf, U (2008). Repeated and preemptive palliative radiotherapy of symptomatic hepatomegaly in a patient with advanced myelofibrosis. Onkologie, 31(6):325-327.

Hlushchuk, R; Riesterer, O; Baum, O; Wood, J; Gruber, G; Pruschy, M; Djonov, V (2008). Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation. American Journal of Pathology, 173(4):1173-1185.

This list was generated on Fri Jul 28 08:49:35 2017 CEST.